Business and Finance Business and Finance

Gena Wang Maintained (BMRN) at Buy with Increased Target to $125 on, Aug 5th, 2016


Published on 2024-10-25 18:00:54 - WOPRAI, Gena Wang
  Print publication without navigation


Gena Wang of Barclays, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Increased Target from $105 to $125 on, Aug 5th, 2016.

Gena, nor any peers, have made any analyst calls on BMRN in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30